• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • Webinars
  • Cisema Participated in Three Webinars in September 2021

Cisema Participated in Three Webinars in September 2021

Tuesday, 28 September 2021 / Published in Webinars

Cisema Participated in Three Webinars in September 2021

In three consecutive days from September 14-16, Cisema presented at three separate successful webinar events: RAPS Convergence 2021, the Cisema Webinar Series Part 3 and the China Health Tech Series III webinar program with Business Finland. Cisema experts discussed various topics from China’s evolving digital health framework to alternative regulatory pathways and medical device registration in China.

On September 14, 2021, Cisema COO Hamish King presented on China’s evolving digital health regulatory framework at a session during the RAPS Convergence 2021, a four-day online event that is one of the largest conferences for regulatory professionals in the life sciences sector globally. Hamish is a RAPS (Regulatory Affairs Professionals Society) member and has also been certified by RAPS with the RAC qualification.

On September 15, 2021, Cisema’s Jacky Li and Hamish King presented a deep-dive of the current existing fast-track channels for the registration of medical devices and IVD in China in Part 3 of the popular Cisema Webinar Series. The webinar also covered other pathways via Hong Kong, the Greater Bay Area and the Hainan Pilot Zone. Feel free to contact us if you would like to watch the replay of the previous three sessions of the Cisema webinar series or are interested in the slides.

On September 16, 2021, Cisema presented in Business Finland’s 2021 China Health Tech Series III to share an overview of the NMPA registration process for medical devices, in-vitro diagnostics and medical software. Markus Roepke and Hamish King presented in the lively and well-received session. The webinar covered software products (SaMD and SiMD) and its regulatory implications in China.

Contact Cisema if you would like to learn more.

What you can read next

Cisema Webinar: Report Launch – The Healthcare Market in China (2021 Update)
China Regulatory 2021 Deep-dive: Major Updates, IVD Regulatory Landscape, evolving Digital Health Frameworks
china compulsory certificate
Cisema Webinar: Certification in China – China Compulsory Certificate (CCC)

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.